Analytical Data
-
基因名
SDF4
- Application
-
别名
SDF4；CAB45；45 kDa calcium-binding Protein
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9BRK5
-
表达区间
37-362aa
-
氨基酸序列
RPANHSSTRERVANREENEILPPDHLNGVKLEMDGHLNRGFHQEVFLGKDLGGFDEDAEPRRSRRKLMVIFSKVDVNTDRKISAKEMQRWIMEKTAEHFQEAMEESKTHFRAVDPDGDGHVSWDEYKVKFLASKGHSEKEVADAIRLNEELKVDEETQEVLENLKDRWYQADSPPADLLLTEEEFLSFLHPEHSRGMLRFMVKEIVRDLDQDGDKQLSVPEFISLPVGTVENQQGQDIDDNWVKDRKKEFEELIDSNHDGIVTAEELESYMDPMNEYNALNEAKQMIAVADENQNHHLEPEEVLKYSEFFTGSKLVDYARSVHEEF
-
分子量
45.4 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SDF4 (Stromal Derived Factor 4) is a chemokine belonging to the CXC family, playing a significant role in immune responses, tissue repair, and inflammation. As research on chemokines advances, SDF4 has gained attention due to its potential implications in various pathological conditions, including cancer, cardiovascular diseases, and autoimmune disorders. The interest in SDF4 is driven by its dual functions in modulating the migration of immune cells and promoting angiogenesis. Understanding the molecular mechanisms of SDF4 has opened new avenues for targeted therapies and novel biomarker development. Recent advancements in recombinant protein technology have enabled the production of SDF4 in sufficient quantities for in-depth functional studies. By generating and characterizing SDF4 recombinant proteins, researchers can investigate its biological activities, receptor interactions, and signaling pathways. This research not only enhances our understanding of SDF4's physiological roles but also its potential applications in clinical therapeutics. Overall, the study of SDF4 recombinant proteins represents a promising frontier in harnessing the therapeutic potential of chemokines for improving human health.
